245 related articles for article (PubMed ID: 19956911)
1. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
Park KH; Shin DG; Kim JR; Hong JH; Cho KH
Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
[TBL] [Abstract][Full Text] [Related]
2. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
Lee JH; Park JH; Lee SH; Kim JR; Cho KH
Int J Mol Med; 2010 Jun; 25(6):945-51. PubMed ID: 20428800
[TBL] [Abstract][Full Text] [Related]
3. Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity.
Park KH; Shin DG; Kim JR; Cho KH
J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):600-10. PubMed ID: 20421239
[TBL] [Abstract][Full Text] [Related]
4. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients.
Cho KH; Park SH; Park JE; Kim YO; Choi I; Kim JJ; Kim JR
Clin Biochem; 2008 Jan; 41(1-2):56-64. PubMed ID: 17996200
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
Granot E
Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
[TBL] [Abstract][Full Text] [Related]
6. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
Kappelle PJ; Bijzet J; Hazenberg BP; Dullaart RP
Arch Med Res; 2011 Apr; 42(3):219-25. PubMed ID: 21722818
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
9. Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes.
Park J; Kim JR; Shin DG; Cho KH
Int J Mol Med; 2012 Apr; 29(4):683-9. PubMed ID: 22211242
[TBL] [Abstract][Full Text] [Related]
10. Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
Watts GF; Ji J; Chan DC; Ooi EM; Johnson AG; Rye KA; Barrett PH
Clin Sci (Lond); 2006 Sep; 111(3):193-9. PubMed ID: 16700661
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
[TBL] [Abstract][Full Text] [Related]
12. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
[TBL] [Abstract][Full Text] [Related]
13. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
15. Female patients with atrial fibrillation have increased oxidized and glycated lipoprotein properties and lower apolipoprotein A-I expression in HDL.
Kim SM; Lee JH; Kim JR; Shin DG; Lee SH; Cho KH
Int J Mol Med; 2011 Jun; 27(6):841-9. PubMed ID: 21399863
[TBL] [Abstract][Full Text] [Related]
16. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
[TBL] [Abstract][Full Text] [Related]
17. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
18. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
Artery; 1993; 20(1):1-18. PubMed ID: 8447724
[TBL] [Abstract][Full Text] [Related]
19. Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patients.
Cho KH; Shin DG; Baek SH; Kim JR
Exp Mol Med; 2009 Feb; 41(2):67-76. PubMed ID: 19287187
[TBL] [Abstract][Full Text] [Related]
20. A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load.
Ai M; Tanaka A; Shimokado K; Ohtani R; Inazu A; Kobayashi J; Mabuchi H; Nakano T; Nakajima K
Ann Clin Biochem; 2009 Nov; 46(Pt 6):457-63. PubMed ID: 19641010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
